Loading…
FDA Cosmetic Safety and Modernization Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,805 other S bills in the 115th — cohort avg 41d
FDA Cosmetic Safety and Modernization Act This bill establishes a series of requirements relating to cosmetics regulation, including requiring cosmetics manufacturers and distributors to report serious adverse health events to the Food and Drug Administration.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2018 · fourth_quarter · Consumer Issues/Safety/Products
Consumer product safety issues related to potential amendments to the FDA's regulatory authorities over cosmetics, including S. 1113, Personal Care Products Safety Act, S. 2003, FDA Cosmetic Safety and Modernization Act; and Modernization of Cosmetics Regulation Act of 2018 (Senate HELP Committee Discussion Draft).
Client expense: Not reported · Firm income: $120,000
Government targets: SENATE
2018 · fourth_quarter · Consumer Issues/Safety/Products
H.R. 575, Cosmetic Modernization Amendments of 2017; S. 1113, Personal Care Products Safety Act; S. 2003, FDA Cosmetic Safety and Modernization Act; Modernization of Cosmetics Regulation Act of 2018 (S. HELP Committee discussion draft); Issues related to sunscreen regulations
Client expense: $370,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Office of the Vice President of the United States, SENATE, U.S. Trade Representative (USTR)
2018 · fourth_quarter · Health Issues
Administrative and legislative monitoring and outreach on issues related to cosmetic regulation and reform. H.R. 575, Cosmetic Modernization Amendments of 2017. S. 1113, Personal Care Products Safety Act. S. 2003, FDA Cosmetic Safety and Modernization Act.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Consumer Issues/Safety/Products
Legislation relating to Cosmetics Reform (chemical safety, cosmetic ingredient safety, and disclosure of fragrance ingredients in consumer products). HR 575; S 1113; S 2003; HR 4964; HR 6903, all provisions. Formation of Congressional Fragrance Caucus.
Client expense: $80,000 · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Health Issues
Legislation and regulations affecting medical devices, pharmaceuticals, cosmetics and other consumer products. Implementation of the 21st Century Cures Act (P.L.114-255). S.1113, Personal Care Products Safety Act. S.2003, FDA Cosmetic Safety and Modernization Act. S.2315, Over-the-Counter Drug Safety, Innovation, and Reform Act. H.R.5333, Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018. H.R.6, SUPPORT for Patients and Communities Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Consumer Issues/Safety/Products
Cosmetics Regulation Consumer protection and product safety standards and regulations in cosmetics industry S. 2003 - FDA Cosmetic Safety and Modernization Act
Client expense: Not reported · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Health Issues
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 1113), FDA Cosmetic Safety and Modernization Act (S. 2003), Modernization of Cosmetics Regulation Act of 2018 (Senate HELP Committee Discussion Draft), Over-the-Counter Drug Safety, Innovation and Reform Act (S. 2315), and Over-the-Counter Monograph Safety, Innovation and Reform Act of 2018 (H.R. 5333)
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Health Issues
SB 1113 - Feinstein/Collins The Personal Care Product Safety Act, Lance/Pallone proposal to reform the current Cosmetic Safety legislation. Senator Hatch Bill on Cosmetic Reform S.2003 Congressman Sessions Cosmetic Reform HR 575
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Health Issues
SB 1113 - Feinstein/Collins The Personal Care Product Safety Act, Lance/Pallone proposal to reform the current Cosmetic Safety legislation. Senator Hatch Bill on Cosmetic Reform S.2003 Congressman Sessions Cosmetic Reform HR 575
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Consumer Issues/Safety/Products
Consumer product safety issues related to potential amendments to the FDA's regulatory authorities over cosmetics, including S. 1113, Personal Care Products Safety Act, S. 2003, FDA Cosmetic Safety and Modernization Act; and Modernization of Cosmetics Regulation Act of 2018 (Senate HELP Committee Discussion Draft).
Client expense: Not reported · Firm income: $140,000
Government targets: SENATE
2018 · third_quarter · Consumer Issues/Safety/Products
Advocate for S. 1113, the Personal Care Products Safety Act; discuss the importance of modernizing the Federal Food, Drug, and Cosmetics Act; monitor for additional efforts to update and modernize the Federal Food, Drug, and Cosmetics Act; monitor S. 2003, the FDA Cosmetic Safety and Modernization Act; educate on FDA regulation and safety in the cosmetics industry.
Client expense: Not reported · Firm income: $90,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Consumer Issues/Safety/Products
H.R. 575, Cosmetic Modernization Amendments of 2017; S. 1113, Personal Care Products Safety Act; S. 2003, FDA Cosmetic Safety and Modernization Act; Issues related to sunscreen regulations
Client expense: $480,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Office of the Vice President of the United States, SENATE, U.S. Trade Representative (USTR)
2018 · third_quarter · Health Issues
Legislation and regulations affecting medical devices, pharmaceuticals, cosmetics and other consumer products. Implementation of the 21st Century Cures Act (P.L.114-255). S.1113, Personal Care Products Safety Act. S.2003, FDA Cosmetic Safety and Modernization Act. S.2315, Over-the-Counter Drug Safety, Innovation, and Reform Act. H.R.5333, Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018. S.2680, Opioid Crisis Response Act of 2018. H.R.6, SUPPORT for Patients and Communities Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Consumer Issues/Safety/Products
Legislation relating to chemical safety, cosmetic ingredients safety, and disclosure of fragrance ingredients in consumer products S. 1113 (Personal Care Products Safety Act), all provisions S. 2003 (FDA Cosmetic Safety and Modernization Act), all provisions H.R.575 (Cosmetic Modernization Amendments of 2017), all provisions H.R. 4964 (Children's Product Warning Label Act of 2018), all provisions H.R. 6903 (Safe Cosmetics and Personal Care Products Act of 2018), all provisions Formation of Congressional Fragrance Caucus
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Consumer Issues/Safety/Products
Legislation relating to Cosmetics Reform (chemical safety, cosmetic ingredient safety, and disclosure of fragrance ingredients in consumer products). HR 575; S 1113; S 2003; HR 4964; HR 6903, all provisions. Formation of Congressional Fragrance Caucus.
Client expense: $80,000 · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Health Issues
Administrative and legislative monitoring and outreach on issues related to cosmetic regulation and reform. H.R. 575, Cosmetic Modernization Amendments of 2017. S. 1113, Personal Care Products Safety Act. S. 2003, FDA Cosmetic Safety and Modernization Act.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Consumer Issues/Safety/Products
Cosmetics Regulation Consumer protection and product safety standards and regulations in cosmetics industry S. 2003 - FDA Cosmetic Safety and Modernization Act
Client expense: Not reported · Firm income: $20,000
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Health Issues
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 1113), FDA Cosmetic Safety and Modernization Act (S. 2003), Modernization of Cosmetics Regulation Act of 2018 (Senate HELP Committee Discussion Draft), Over-the-Counter Drug Safety, Innovation and Reform Act (S. 2315), and Over-the-Counter Monograph Safety, Innovation and Reform Act of 2018 (H.R. 5333)
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Consumer Issues/Safety/Products
Legislation relating to chemical safety, cosmetic ingredients safety, and disclosure of fragrance ingredients in consumer products S. 1113 (Personal Care Products Safety Act), all provisions S. 2003 (FDA Cosmetic Safety and Modernization Act), all provisions H.R.575 (Cosmetic Modernization Amendments of 2017), all provisions H.R. 4964 (Children's Product Warning Label Act of 2018), all provisions Formation of Congressional Fragrance Caucus
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Health Issues
Administrative and legislative monitoring and outreach on issues related to cosmetic regulation and reform. H.R. 575, Cosmetic Modernization Amendments of 2017. S. 1113, Personal Care Products Safety Act. S. 2003, FDA Cosmetic Safety and Modernization Act.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES
2018 · second_quarter · Consumer Issues/Safety/Products
Monitor S. 2003, the FDA Cosmetic Safety and Modernization Act; educate on FDA regulation and safety in the cosmetics industry.
Client expense: Not reported · Firm income: $90,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Consumer Issues/Safety/Products
Cosmetics Regulation Consumer protection and product safety standards and regulations in cosmetics industry S. 2003 - FDA Cosmetic Safety and Modernization Act
Client expense: Not reported · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Consumer Issues/Safety/Products
Legislation relating to Cosmetics Reform (chemical safety, cosmetic ingredient safety, and disclosure of fragrance ingredients in consumer products). HR 575; S 1113; S 2003; HR 4964, all provisions. Formation of Congressional Fragrance Caucus.
Client expense: $80,000 · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Consumer Issues/Safety/Products
Consumer product safety issues related to potential amendments to the FDA's regulatory authorities over cosmetics, including S. 1113, Personal Care Products Safety Act, S. 2003, FDA Cosmetic Safety and Modernization Act; and Modernization of Cosmetics Regulation Act of 2018 (Senate HELP Committee Discussion Draft).
Client expense: Not reported · Firm income: $140,000
Government targets: SENATE
2018 · second_quarter · Consumer Issues/Safety/Products
H.R. 575, Cosmetic Modernization Amendments of 2017; S. 1113, Personal Care Products Safety Act; S. 2003, FDA Cosmetic Safety and Modernization Act
Client expense: $510,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2018 · second_quarter · Consumer Issues/Safety/Products
S. 2003 - The FDA Cosmetic Safety and Modernization Act, all sections. S. 1113 - Personal Care Products Safety Act, all sections. H.R.575 - Cosmetic Modernization Amendments of 2017, all sections. H.R. 5333-Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018, any sections pertaining to sunscreen and GRASE findings. S. 2315-Over-the-Counter Drug Safety, Innovation, and Reform Act, any sections pertaining to sunscreen and GRASE findings. S._____- Draft legislation to Amend the Federal Food, Drug, and Cosmetic Act to Ensure the Safety of Cosmetics. H.R. ______ - Draft legislation to Amend the Federal Food, Drug, and Cosmetic Act to Ensure the Safety of Cosmetics.
Client expense: $192,562 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Consumer Issues/Safety/Products
H.R.142, Dangerous Products Warning Act H.R.575, Cosmetic Modernization Amendments of 2017 H.R.2728, Cleaning Product Labeling Act of 2017 H.R.2790, Humane Cosmetics Act H.R.3409, Anti-Pyramid Promotional Scheme Act of 2017 H.R.4544, Consumer Data Protection Act H.R.5165, Ending Forced Arbitration for Victims of Data Breaches Act of 2018 H.R.5166, Protecting Consumer Information Act of 2018 H.R.5548, To require a study on the presence of personal care products in drinking water S.2003, FDA Cosmetic Safety and Modernization Act S.2124, Consumer Privacy Protection Act of 2017 S.2179, Data Security and Breach Notification Act
Client expense: $150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Health Issues
Legislation and regulations affecting medical devices, pharmaceuticals, cosmetics and other consumer products. Implementation of the 21st Century Cures Act (P.L.114-255). S.1113, Personal Care Products Safety Act. S.2003, FDA Cosmetic Safety and Modernization Act. OTC Monograph Reform. S.2680, Opioid Crisis Response Act of 2018.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Health Issues
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 1113), FDA Cosmetic Safety and Modernization Act (S. 2003), Modernization of Cosmetics Regulation Act of 2018 (Senate HELP Committee Discussion Draft), Over-the-Counter Drug Safety, Innovation and Reform Act (S. 2315), and Over-the-Counter Monograph Safety, Innovation and Reform Act of 2018 (H.R. 5333)
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Health Issues
Advocate for S. 1113, the Personal Care Products Safety Act; monitor S. 2003, the FDA Cosmetic Safety and Modernization Act; educate on FDA regulation and safety in the cosmetic industry; monitor cyber security and privacy issues.
Client expense: Not reported · Firm income: Not reported
2018 · second_quarter · Telecommunications
Advocate for S. 1113, the Personal Care Products Safety Act; monitor S. 2003, the FDA Cosmetic Safety and Modernization Act; educate on FDA regulation and safety in the cosmetic industry; monitor cyber security and privacy issues.
Client expense: Not reported · Firm income: Not reported
2018 · second_quarter · Consumer Issues/Safety/Products
Advocate for S. 1113, the Personal Care Products Safety Act; monitor S. 2003, the FDA Cosmetic Safety and Modernization Act; educate on FDA regulation and safety in the cosmetic industry; monitor cyber security and privacy issues.
Client expense: Not reported · Firm income: Not reported
2018 · first_quarter · Consumer Issues/Safety/Products
Legislation relating to Cosmetics Reform (chemical safety, cosmetic ingredient safety, and disclosure of fragrance ingredients in consumer products). HR 575; S 1113; S 2003; HR 4964, all provisions
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Consumer Issues/Safety/Products
S.2003 - FDA Cosmetic Safety and Modernization Act
Client expense: $25,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Consumer Issues/Safety/Products
H.R. 575, Cosmetic Modernization Amendments of 2017; S. 1113, Personal Care Products Safety Act; S. 2003, FDA Cosmetic Safety and Modernization Act
Client expense: $500,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2018 · first_quarter · Consumer Issues/Safety/Products
H.R.142, Dangerous Products Warning Act H.R.575, Cosmetic Modernization Amendments of 2017 H.R.2728, Cleaning Product Labeling Act of 2017 H.R.2790, Humane Cosmetics Act H.R.3409, Anti-Pyramid Promotional Scheme Act of 2017 H.R.4544, Consumer Data Protection Act H.R.5165, Ending Forced Arbitration for Victims of Data Breaches Act of 2018 H.R.5166, Protecting Consumer Information Act of 2018 H.R.5548, To require a study on the presence of personal care products in drinking water S.2003, FDA Cosmetic Safety and Modernization Act S.2124, Consumer Privacy Protection Act of 2017 S.2179, Data Security and Breach Notification Act
Client expense: $150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Consumer Issues/Safety/Products
Legislation relating to chemical safety, cosmetic ingredients safety, and disclosure of fragrance ingredients in consumer products S. 1113 (Personal Care Products Safety Act), all provisions S. 2003 (FDA Cosmetic Safety and Modernization Act), all provisions H.R.575 (Cosmetic Modernization Amendments of 2017), all provisions H.R. 4964 (Children's Product Warning Label Act of 2018), all provisions
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Health Issues
Legislation and regulations affecting medical devices, pharmaceuticals, cosmetics and other consumer products. Implementation of the 21st Century Cures Act (P.L.114-255). S.1113, Personal Care Products Safety Act. S.2003, FDA Cosmetic Safety and Modernization Act. OTC Monograph Reform. H.R.1892, Bipartisan Budget Act of 2018 (P.L.115-123)/H.R.1625, Consolidated Appropriations Act, 2018 (P.L.115-141).
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Consumer Issues/Safety/Products
S. 2003 - The FDA Cosmetic Safety and Modernization Act, all sections; S. 1113 - Personal Care Products Safety Act, all sections; H.R.575 - Cosmetic Modernization Amendments of 2017, all sections; S._____- Draft legislation to Amend the Federal Food, Drug, and Cosmetic Act to Ensure the Safety of Cosmetics; H.R. ______ - Draft legislation to Amend the Federal Food, Drug, and Cosmetic Act to Ensure the Safety of Cosmetics.
Client expense: $139,495 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Consumer Issues/Safety/Products
Cosmetics Regulation Consumer protection and product safety standards and regulations in cosmetics industry S. 2003 - FDA Cosmetic Safety and Modernization Act
Client expense: Not reported · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Health Issues
OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 1113), FDA Cosmetic Safety and Modernization Act (S. 2003), Modernization of Cosmetics Regulation Act of 2018 (Senate HELP Committee Discussion Draft), Over-the-Counter Drug Safety, Innovation and Reform Act (S. 2315), and Over-the-Counter Monograph Safety, Innovation and Reform Act of 2018 (H.R. 5333)
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Consumer Issues/Safety/Products
Consumer product safety issues related to potential amendments to the FDA's regulatory authorities over cosmetics, including S. 1113, Personal Care Products Safety Act, and S. 2003, FDA Cosmetic Safety and Modernization Act.
Client expense: Not reported · Firm income: $110,000
Government targets: SENATE
2017 · fourth_quarter · Consumer Issues/Safety/Products
H.R.142, Dangerous Products Warning Act H.R.575, Cosmetic Modernization Amendments of 2017 H.R.2728, Cleaning Product Labeling Act of 2017 H.R.2790, Humane Cosmetics Act H.R.3409, Anti-Pyramid Promotional Scheme Act of 2017 H.R.4544, Consumer Data Protection Act H.R.5165, Ending Forced Arbitration for Victims of Data Breaches Act of 2018 H.R.5166, Protecting Consumer Information Act of 2018 S.2003, FDA Cosmetic Safety and Modernization Act S.2124, Consumer Privacy Protection Act of 2017 S.2179, Data Security and Breach Notification Act
Client expense: $150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · fourth_quarter · Consumer Issues/Safety/Products
Consumer product safety issues related to potential amendments to the FDA's regulatory authorities over cosmetics, including S. 1113, Personal Care Products Safety Act, and S. 2003, FDA Cosmetic Safety and Modernization Act.
Client expense: Not reported · Firm income: $110,000
Government targets: SENATE
2017 · fourth_quarter · Consumer Issues/Safety/Products
H.R. 575, Cosmetic Modernization Amendments of 2017; S. 1113, Personal Care Products Safety Act; S. 2003, FDA Cosmetic Safety and Modernization Act
Client expense: $400,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2017 · fourth_quarter · Consumer Issues/Safety/Products
S.1113, "Personal Care Products Safety Act", issues relating to the regulation of cosmetics. S.2003, "FDA Cosmetic Safety and Modernization Act, issues relating to the regulation of cosmetics.
Client expense: $420,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, U.S. Postal Service (USPS)
2017 · fourth_quarter · Health Issues
Legislation and regulations affecting medical devices, pharmaceuticals, cosmetics and other consumer products. Implementation of the 21st Century Cures Act (P.L.114-255). S.1113, Personal Care Products Safety Act. S.2003, FDA Cosmetic Safety and Modernization Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · fourth_quarter · Consumer Issues/Safety/Products
S. 2003- The FDA Cosmetic Safety and Modernization Act, all sections; S.1113 - Personal Care Products Safety Act, all sections; H.R.575 - Cosmetic Modernization Amendments of 2017, all sections; S. ______ - Draft legislation To Amend the Federal Food, Drug, and Cosmetic Act to Ensure the Safety of Cosmetics; and H.R. ______ - Draft legislation To Amend the Federal Food, Drug, and Cosmetic Act to Ensure the Safety of Cosmetics.
Client expense: $146,800 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · fourth_quarter · Consumer Issues/Safety/Products
Legislation relating to chemical safety, cosmetic ingredients safety, and disclosure of fragrance ingredients in consumer products S. 1113 (Personal Care Products Safety Act), all provisions S. 2003 (FDA Cosmetic Safety and Modernization Act), all provisions
Client expense: Not reported · Firm income: $40,000
Government targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2017 · fourth_quarter · Consumer Issues/Safety/Products
Legislation relating to Cosmetics Reform (chemical safety, cosmetic ingredient safety, and disclosure of fragrance ingredients in consumer products). HR 575; S 1113; S 2003, all provisions
Client expense: $80,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE